Published in
Elsevier, International Journal of Antimicrobial Agents, 3(57), p. 106274, 2021
DOI: 10.1016/j.ijantimicag.2020.106274
Links
Tools
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
Journal article published in 2020 by
Marion Plaze,
David Attali 
,
Matthieu Prot,
Anne-Cécile Petit ,
Michael Blatzer,
Fabien Vinckier,
Laurine Levillayer,
Jeanne Chiaravalli,
Florent Perin-Dureau,
Arnaud Cachia,
Gérard Friedlander,
Fabrice Chrétien,
Etienne Simon-Loriere,
Raphaël Gaillard
,
Matthieu Prot,
Anne-Cécile Petit ,
Michael Blatzer,
Fabien Vinckier,
Laurine Levillayer,
Jeanne Chiaravalli,
Florent Perin-Dureau,
Arnaud Cachia,
Gérard Friedlander,
Fabrice Chrétien,
Etienne Simon-Loriere,
Raphaël Gaillard
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 